Pemeriksaan Laboratorium pada Coronavirus Disease 2019 (COVID-19)

Yusra, Yusra; Pangestu, Natasha

doi:10.36408/mhjcm.v7i1a.472

Cited by 8 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Patients who will undergo elective and cito caesarean section and inpartum must be screened according to the flow for obstetric patients (5). However, with the limited facilities and infrastructure at Bangli General Hospital and in Indonesia, adjustments are made by combining the flow with the Indonesian Ministry of Health guidelines and recommendations from the COVID-19 Accelerated Handling Task Force (7,8). In accordance with the recommendations of the COVID-19 Accelerated Handling Task Force, rapid tests must be carried out on pregnant women before giving birth, except for referral cases where rapid tests have been carried out or pregnant women who have confirmed COVID-19.…”

Section: Discussionmentioning

confidence: 99%

Development of Caesarean Section Clinical Pathway: A Lesson Learned

Sastrawan¹,

Wardhani²

2022

JKB

View full text Add to dashboard Cite

Although clinical pathway (CP) is aimed to ensure quality and cost, the development of CP at hospitals is primarily for administrative purposes as it is required by accreditation standards, thus causing high variations in its implementation. This study aimed to develop a clinical pathway for caesarean section and explore the problem during development and implementation test. The selection of caesarean section was based on high volume, risk, and cost. Using participatory action research, the researcher started the program by performing an implementation evaluation, literature review, and regulatory development. The evaluation identified implementation discrepancies and prolonged length of stay. Based on the evaluation and literature review results, the Professional Care Provider (PCP) in the hospital conducted discussions and made suggestions by considering available resources, current practices, and behavior. The main differences of the new clinical pathway are: 1) it is developed based on literature and current practice, and 2) it should be added with notification, explanation, inclusion and exclusion criteria, and references. Before the implementation test, the hospital provide resources, develops a standard operational procedure followed by monitoring and evaluation. Differences in the type of medication and documentation method were found, which then further discussed with all involved PCP to define the agreed solutions. Professional engagement and openness culture that embraces along the process are the main key lesson learned in addition to the understanding that CP development and implementation is a continuous learning process.

show abstract

Section: Discussionmentioning

confidence: 99%

Development of Caesarean Section Clinical Pathway: A Lesson Learned

Sastrawan¹,

Wardhani²

2022

JKB

View full text Add to dashboard Cite

show abstract

“…Reaction (RT-PCR), pemeriksaan hematologi rutin dan D-dimer dapat digunakan sebagai data pendukung pemeriksaan baku emas ini (Yusra, 2020). D-dimer merupakan parameter pemeriksaan laboratorium yang memberikan gambaran ada atau tidaknya penggumpalan di dalam darah.…”

Section: Pemeriksaan Penunjang Covid-19 Yaitu Real Time Reverse Polym...unclassified

Gambaran Hematologi Rutin Dan D-Dimer Pasien Covid-19 Kota Kupang

2023

View full text Add to dashboard Cite

COVID-19 merupakan penyakit infeksius menular yang di sebabkan oleh SARS-CoV-2 Coronavirus yang dapat menyebabkan kematian. Pemeriksaan laboratorium yang dilakukan pada covid-19 adalah Real Time Reverse Polymerase Chain Reaction (RT-PCR) dan sebagai data pendukung dapat juga dilakukan pemeriksaan hematologi rutin serta mengukur tingkat D-Dimer. Mengukur tingkat D-dimer pada awal terjadinya penyakit dapat berguna dalam mengendalikan dan mengelola panyakit COVID-19. Tujuan penelitian ini untuk mengetahui gambaran hematologi rutin dan D-dimer pasien COVID-19 Kota Kupang. Jenis penelitian yang di gunakan yaitu deskriptif dengan pendekatan secara cross sectional menggunakan data sekunder, jumlah sampel yang memenuhi kriteria inklusi dan eksklusi sebanyak 292 orang. Hasil penelitian menujukkan pasien terkonfirmasi COVID-19 paling tinggi pada usia 31-35 tahun 91 (31%) dan paling rendah pada usia 0-5 tahun 12 (14%), lebih tinggi pada laki-laki 151 (52%). Gambaran hasil hematologi rutin dari 292 pasien didominasi normal dan pada beberapa kasus mengalami sedikit penigkatan dan penurunan. Nilai D-dimer dari 79 pasien COVID-19 mengalami peningkatan sebanyak 54 (63%). Disimpulkan bahwa pasien terkonfirmasi COVID-19 dapat mengalami peningkatan nilai D-dimer sehingga penting untuk memantau kadar D-dimer dalam masa perawatan pasien.

show abstract

“…Pemeriksaan laboratorium sangat penting dalam penanganan COVID-19, mulai dari diagnosis, pemantauan terapi, penentuan prognosis, sampai dengan surveilans. Pemeriksaan laboratorium yang dapat dilakukan untuk pemeriksaan COVID-19 antara lain pemeriksaan Polymerase Chain Reaction (PCR), imunologi, dan hematologi (Yusra & Pangestu, 2020).…”

Section: Abstrakunclassified

NILAI NEUTROPHIL LYMPHOCYTE RATIO (NLR) PADA PASIEN COVID-19 DI RSUD Dr. H. MOCH. ANSARI SALEH BANJARMASIN

Hikmah¹,

Farihi²,

Salman³

et al. 2022

MAK

View full text Add to dashboard Cite

Coronavirus Disease 19 (COVID-19) is a disease caused by Severe Acute Respiratory Syndrome Coronavirus 2. The number of COVID-19 cases recorded was 10,273,001 worldwide on December 2019, to June 2020, with a total mortality of 505,295. One of the parameters of laboratory tests to predict the patient's condition is the measurement of the Neutrophil Lymphocyte Ratio (NLR), which is used to determine the prognosis of patients in various clinical situations. This study aims to determine the description of NLR in COVID-19 patients at RSUD Dr. H. Moch. Ansari Saleh Banjarmasin in 2021. This research is quantitative. with a cross sectional design. The research variable is the NLR value of COVID-19 patients, the sub-variable is based on age, gender, and disease history. Data were taken from January to December 2021. The sample in this study were COVID-19 patients who get NLR examinations at RSUD Dr. H. Moch. Ansari Saleh Banjarmasin as many as 280 patients with cluster random sampling. This study obtained an average NLR value of 7.31, the majority NLR value of high risk category was 199 patients (71.07%). Based on the age group the most patients with high risk category were 102 patients (36.4%) with an average NLR value was 10.59. The average NLR value by gender, male patients 7.82 and female patients 6.89. Based on medical history, there were 173 patients (61.8%) with an average NLR value of 9.20. Based on these results, it can be concluded that the NLR value is high risk in COVID-19 patients who have a history of disease (hypertension, pneumonia, and diabetes mellitus) and patients aged >50 years.

show abstract

Pemeriksaan Laboratorium pada Coronavirus Disease 2019 (COVID-19)

Cited by 8 publications

References 0 publications

Development of Caesarean Section Clinical Pathway: A Lesson Learned

Development of Caesarean Section Clinical Pathway: A Lesson Learned

Gambaran Hematologi Rutin Dan D-Dimer Pasien Covid-19 Kota Kupang

NILAI NEUTROPHIL LYMPHOCYTE RATIO (NLR) PADA PASIEN COVID-19 DI RSUD Dr. H. MOCH. ANSARI SALEH BANJARMASIN

Contact Info

Product

Resources

About